GeoVax Labs, Inc. (GOVX) Second Generation HIV Vaccine will be Subject of HIV Vaccine Trials Network Phase 1 Trial
GeoVax Labs, an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced that enrollment…